Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 11.82
0.00 (0.00%)
At close: Aug 14, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 550.08 million as of August 14, 2026. Its market cap has decreased by -28.71% in one year.
Market Cap
550.08M
Enterprise Value
127.15M
Revenue
67.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.82
ChartMarket Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 550.08M, a decrease of -63.75%. That is a compound annual growth rate of -37.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 550.08M | -38.63% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.55B |
| Nanexa AB | 868.50M |
| Dicot Pharma AB | 702.76M |
| EQL Pharma AB | 699.85M |
| Orexo AB | 546.87M |
| Moberg Pharma AB | 514.19M |
| Enzymatica AB | 497.61M |
| Klaria Pharma Holding AB (publ.) | 226.30M |